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Abstract
Background: In women with singleton pregnancies, maternal adaptation is considered a stress test for later life
cardiovascular disease. The aim of this study was to assess maternal adaptation in women with twin pregnancies
compared to women carrying singletons during and after pregnancy.
Methods: This was a population based prospective cohort study of 91 women with twin pregnancies and 8107
women carrying singletons. The association of twin pregnancy and maternal adaptation was examined using
regression analyses. In pregnancy, we measured soluble fms-like tyrosine kinase-1 (sFLT-1), placental growth (PGF)
factor, systolic (SBP) and diastolic blood pressure (DBP), and the occurrence of pre-eclampsia (PE). After pregnancy,
measurements were obtained on SBP and DBP, cardiac function, retinal calibres, intima media thickness and
distensibility of the common carotid artery.
Results: sFLT-1 and PGF concentrations were higher in early (13.4 weeks) and mid-pregnancy (20.4 weeks) in
women with twin pregnancies compared to women with singleton pregnancies. Women with twin pregnancies
had a different DBP pattern in pregnancy. Women with twin pregnancies were more likely to have PE (odds ratio
3.63; 95% CI [1.76 to 7.48]). Six and ten years after pregnancy, no differences in maternal adaptation were observed.
Conclusions: Women with twin pregnancies show an altered adaptation during pregnancy compared to women
with singleton pregnancies. This is associated with a substantially increased incidence of PE, but does not lead to
persistent altered maternal adaptation years after pregnancy.
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Background
In pregnancy, extensive maternal cardiovascular adapta-
tions lead to proper implantation and placental and fetal
growth and development. Women failing to meet the
hemodynamic demands of pregnancy are more likely to
develop complications such as pre-eclampsia (PE). These
women also have an increased risk to develop cardiovas-
cular disease (CVD) later in life [1]. The associations
may be explained by persisting endothelial damage of
pregnancy and/or a pre-existing unfavourable cardiovas-
cular risk profile [2, 3]. Therefore, pregnancy can be
considered as a hemodynamic stress test for long term
CVD [3].
Twin pregnancy has been marked as a risk factor of
PE [4–6], and may be explained by the higher demand
of both foetuses from the mother. This leads to different
maternal adaptation to pregnancy [7–9], in response to
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altered placentation with increased anti-angiogenic fac-
tors as soluble fms-like tyrosine kinase-1 (sFLT-1) and
pro-angiogenic factors as placental growth factor (PGF).
The adaptation to pregnancy is more often inadequate
in women with twin pregnancies conceived after assisted
reproductive techniques (ART), leading to an even more
increased risk of PE [10]. This relation may be explained
by the fact that women who conceived after ART are
more often older [11–13]. They are also more often nul-
liparous, which is associated with PE [14].
Given this knowledge on the association of twin preg-
nancies with PE and the association of PE with CVD, we
hypothesize that women with twin pregnancies have an
increased risk of future CVD, which is mediated by the in-
creased risk of PE. Therefore, the aim of this study was to
investigate maternal adaptation throughout pregnancy
and years after pregnancy in women with twin pregnan-
cies compared to women with singleton pregnancies.
Methods
Study design
This study was embedded within The Generation R
Study. Generation R is an ongoing population-based
prospective cohort study from early pregnancy onwards
[15]. Mothers with a delivery date between April 2002
and January 2006 were eligible for participation. Stan-
dardized examinations were performed within mothers
during pregnancy, and within both mother and child 6
and 10 years later. The Medical Ethical Committee of
The Erasmus Medical Centre in Rotterdam approved the
study (MEC 198.782/2001/31). Written informed con-
sent was obtained from all mothers. Women with a live
born singleton or twin pregnancy with at least one
measurement available on cardiovascular parameters
during and after pregnancy were included in this study.
Women who participated more than one time in the co-
hort were excluded (i.e. with different pregnancies). The
total population for analyses comprised 8198 women
(Additional file 1: Figure S1). All women were invited to
standardized visits three times during pregnancy and 6
and 10 years after pregnancy at the research centre.
Pregnancy
Early in pregnancy (median 13.4 weeks of gestational
age, 90% range 10.5 to 17.2) and in mid-pregnancy (me-
dian 20.4 weeks of gestational age, 90% range 18.8 to
23.1), we obtained maternal non-fasting venous blood
samples [16, 17]. sFLT-1 and PGF concentrations were
determined. sFLT-1 and PGF vary with gestational age
and concentrations are therefore not normally distrib-
uted. We constructed sFLT-1 and PGF gestational-age-
adjusted standardized Multiple of the Median (MoM)
scores, which we used in all analyses [18].
Late in pregnancy (median 30.2 weeks of gestational
age, 90% range 28.9 to 32.2) we performed Doppler velo-
cimetry of the uterine arteries to measure the uterine ar-
tery resistance index (UtA-RI) as described previously
[19]. Doppler measurements showed a high intraclass
correlation coefficient value (> 0.80) with corresponding
low coefficient of variation value (< 10%), which indi-
cates adequate reproducibility [20].
Trained research assistants wearing usual clothing (i.e.
no white coats) measured systolic and diastolic blood
pressures in early, mid-, and late pregnancy in the right
upper arm [21]. Before the measurement, women sat in
an upright position with back support and relaxed for 5
min. The mean value of two blood pressure readings over
a 60-s interval was documented.
Pre-eclampsia
We obtained information on clinically diagnosed PE
from cross-checked original hospital charts [22]. Given
this study design (prospective cohort study), we defined
the occurrence of PE according to the ISSHP criteria
that were in effect at the time of the study, as new onset
systolic blood pressure ≥ 140 mmHg and/or diastolic
blood pressure ≥ 90mmHg after 20 weeks of gestation
and the presence of proteinuria with no evidence of
urinary tract infection in a random urine sample [23].
Six years after pregnancy
Six years (median 6.1 years, 90% range 5.6 to 7.6) after
pregnancy blood pressure was measured with the vali-
dated automatic sphygmomanometer Datascope Accu-
torr Plus (Paramus, NJ, USA) [24]. Two-dimensional M-
mode echocardiographic measurements were performed
as described previously [25]. To assess aortic stiffness we
used carotid-femoral pulse wave velocity (PWV) [26,
27]. Retinal vascular calibres were assessed by taking
digital retinal photographs [28].
Ten years after pregnancy
Ten years after pregnancy (median 9.8 years, 90% range
9.4 to 10.6) blood pressure was measured with the vali-
dated automatic sphygmomanometer Datascope Accu-
torr Plus (Paramus, NJ, USA) [24]. The common carotid
artery (CCA) was measured using the ATL-Philips
Model HDI 5000 (Seattle, WA, USA) or the Logiq E9
(GE Medical Systems, Wauwatosa, WI, USA) device 10
years after pregnancy. Carotid distensibility is a measure
of carotid artery elasticity that has been introduced as a
risk factor for cardiovascular disease [29]. Intima media
thickness (IMT) is a measure of subclinical atheroscler-
osis associated with cardiovascular risk factors. Common
carotid distensibility and IMT were assessed with the
subjects in supine position, with the head tilted slightly
to the contralateral side for the measurement in the
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common carotid artery. A region at 1.5 cm proximal to
the origin of the bulb of the carotid artery was identified
with the use of ultrasound. The end-diastolic diameter
(D), the absolute stroke change in diameter during sys-
tole (ΔD), the relative stroke change in diameter (ΔD/D)
and IMT were computed as the mean of three successive
recordings from both left and right side. The cross-
sectional arterial wall distensibility coefficient was calcu-
lated according to the following equation: distensibility
coefficient = 2ΔD/(Dxpulse pressure) (10− 3 kPa). In a re-
producibility study performed among 50 subjects, the
intraclass correlation coefficient was 0.90 for distensibil-
ity and 0.91 for IMT.
Covariates
We obtained information on maternal age, ethnicity,
educational level, parity, smoking and method of con-
ception through questionnaires repeatedly applied dur-
ing pregnancy. At study enrolment during pregnancy,
we measured maternal height (cm) and weight (kg) with-
out shoes. Body mass index (BMI) was calculated (kg/
m2). Community midwifery and hospital registries pro-
vided information on gestational age at birth, birth
weight and placental weight.
Statistical analysis
In this study, all available women with twin pregnancies
(n = 91) were compared to all women with singleton
pregnancies (n = 8107). Independent Student’s t, Mann-
Whitney U and Chi-square tests were performed to test
the differences in baseline characteristics between
women with singleton and twin pregnancies.
Pregnancy
Linear regression analyses were performed to relate
women with singleton or twin pregnancies to placental
biomarkers, blood pressure, uterine artery Doppler mea-
surements, and cardiovascular outcomes at follow-up.
Logistic regression analyses were performed to relate
women with singleton or twin pregnancies to PE. For
placental biomarkers, blood pressure in pregnancy and
uterine artery Doppler measurements basic models were
adjusted for maternal age and gestational age at time of
measurement. If MoMs were used, measurements were
not additionally adjusted for gestational age at time of
measurement. In the multivariate analyses, we addition-
ally adjusted for ethnicity, educational level, parity,
smoking, method of conception and BMI at intake. For
PE, the basic model was adjusted for gestational age at
birth. To examine the role of the placenta, placental
weight was added to the placenta model, and the medi-
ating role of early pregnancy sFLT-1 and PGF as proxy
for placental function were used. We analysed the direct
causal mediation effects through mediation analyses. To
explore blood pressure trajectories in pregnancy between
women with singleton and twin pregnancies repeated
measurement regression models were performed using
the mixed model procedure with maternal blood pres-
sure as repeated outcome measure. These models take
the correlation between repeated measurements of the
same woman into account.
Maternal outcomes years after pregnancy
For outcomes 6 and 10 years after pregnancy, a linear
regression basic model was adjusted for maternal age
and interval time. The multivariate analyses were add-
itionally adjusted for ethnicity, educational level, parity,
smoking, method of conception and BMI at intake.
When assessing retinal arteriolar calibre, we additionally
adjusted for retinal venular calibre and vice versa. PWV
was additionally adjusted for pulse at the time of PWV
assessment.
Missing values in covariates were multiple-imputed, by
using Markov chain Monte Carlo approach [30]. Five
imputed data sets were created and analysed together.
Statistical analyses were performed using Statistical
Package of Social Sciences version 21.0 for Windows
(SPSS, IBM Corp., Armonk, NY, USA), Statistical Ana-
lysis System version 9.4 (SAS, Institute Inc., Cary, NC,
USA) and R version 3.5.0 (R Foundation, Vienna,
Austria).
Results
Table 1 shows maternal characteristics during pregnancy
and 6 and 10 years after pregnancy. Woman with twin
pregnancies were more often of Western ethnicity, mul-
tiparous, older, and had more pregnancies conceived by
ART (Table 1).
Pregnancy
Women with twin pregnancies had higher levels of
sFLT-1 and PGF in early and mid-pregnancy (Table 2).
In total, 179 women (2.2%) developed PE; 168 women
(2.1%) with a singleton and 11 women (12.1%) with twin
pregnancies. Of these 179 women, 20 (11.2%) had early
onset PE (< 34 weeks of gestation). Women with twin
pregnancies had a higher risk to develop PE (OR 3.63;
95% CI 1.76 to 7.48) compared to women with singleton
pregnancies. The risk to develop PE was even higher if
we took placental weight into account (OR 6.76; 95% CI
2.81 to 16.24). This was mediated by placental function
represented by sFLT-1 and PGF levels in early preg-
nancy. Despite this mediation through placental func-
tion, women with twin pregnancies still had a higher
incidence of PE (Table 3). Women with twin pregnan-
cies and PE showed no difference in sFLT-1 and PGF
compared to women with twin pregnancies without PE
(data not shown).
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Table 1 Baseline characteristics (n = 8198)
Singleton
(n = 8107)
Twin
(n = 91)
P-value
Intake
Maternal age (years) 29.5 (5.3) 32.1 (4.4) < 0.001
Non-Western ethnicity (%) 3660 (45.1) 27 (29.7) 0.01
Lower education (%) 4978 (61.4) 46 (50.5) 0.05
Nulliparous (%) 4761 (58.7) 44 (48.4) 0.04
Assisted conception (%) 539 (6.6) 14 (15.4) 0.001
BMI at intake (kg/m2) 24.1 (19.5 to 34.0) 24.1 (19.1 to 36.0) 0.37
Smoking during pregnancy (%) 2382 (29.4) 28 (30.8) 0.68
Early pregnancy
sFLT (pg./mL) 5.1 (2.2 to 12.0) 8.1 (3.6 to 15.8) < 0.001
PGF (pg./mL) 43.4 (17.5 to 157.7) 46.6 (16.2 to 226.2) 0.62
SBP (mmHg) 115.7 (12.4) 116.8 (12.0) 0.45
DBP (mmHg) 68.4 (9.6) 68.9 (10.1) 0.68
Mid-pregnancy
sFLT (pg./mL) 5.0 (1.9 to 14.3) 9.5 (2.7 to 24.6) < 0.001
PGF (pg./mL) 202.4 (89.1 to 525.4) 405.0 (108.4 to 1183.8) < 0.001
SBP (mmHg) 116.8 (12.1) 118.9 (12.1) 0.11
DBP (mmHg) 67.3 (9.4) 67.5 (9.8) 0.82
Late pregnancy
SBP (mmHg) 118.3 (12.1) 119.5 (12.1) 0.42
DBP (mmHg) 69.2 (9.4) 71.0 (11.5) 0.10
Birth
Gestational age at birth (weeks) 40.1 (36.7 to 42.1) 37.0 (30.8 to 39.5) < 0.001
Premature birth < 37 weeks (%) 442 (5.5) 45 (49.5) < 0.001
Premature birth < 34 weeks (%) 113 (1.4) 13 (14.3) < 0.001
Birth weight (g) 3398.9 (561.7) 2470.2 (620.4) < 0.001
Weight placenta (g) 633.4 (147.6) 1016.5 (235.7) < 0.001
Pre-eclampsia (%) 168 (2.1) 11 (12.1) < 0.001
Six years after pregnancy
Interval time (years) 6.1 (5.6 to 7.6) 6.1 (5.7 to 7.4) 0.75
BMI (kg/m2) 24.8 (19.8 to 36.0) 24.4 (19.5 to 39.1) 0.61
Central retinal arteriolar calibre (SDS) 145.3 (16.9) 143.5 (17.3) 0.56
Central retinal venular calibre (SDS) 206.9 (22.5) 206.3 (24.5) 0.89
Pulse wave velocity (m/s) 7.6 (1.1) 7.4 (0.9) 0.45
Fractional shortening 37.0 (4.9) 36.4 (4.6) 0.37
Aortic root diameter (mm) 27.7 (2.9) 27.8 (2.8) 0.98
Left atrial diameter (mm) 33.9 (3.8) 34.2 (3.8) 0.48
Left ventricular mass (g) 127.0 (84.0 to 187.0) 133.0 (88.2 to 200.0) 0.05
SBP (mmHg) 119.4 (13.1) 119.3 (13.7) 0.97
DBP (mmHg) 71.0 (10.1) 70.1 (10.5) 0.51
Ten years after pregnancy
Interval time (years) 9.8 (9.4 to 10.6) 9.8 (9.3 to 10.4) 0.27
BMI (kg/m2) 24.9 (20.0 to 36.2) 24.9 (20.3 to 39.9) 0.63
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Figure 1 shows blood pressure patterns during preg-
nancy for women with twin pregnancies compared to
women with a singleton pregnancies. A different DBP
(p < 0.05), but not SBP (p-value 0.89) pattern was ob-
served for women with twin pregnancies compared to
women with singleton pregnancies with a cross-over in
the DBP pattern around 15 weeks of gestation. This dif-
ference in DBP pattern was still observed after adjust-
ment for confounders. Women with twin pregnancies
and PE start with a higher DBP in early pregnancy com-
pared to women with twin pregnancies without PE (p =
0.02). No difference in SBP or DBP pattern was
observed.
Maternal outcomes years after pregnancy
Twin pregnancies were not associated with SBP or DBP
6 years after pregnancy. Women with twin pregnancies
had a lower SBP 10 years after pregnancy (β −4.44, 95%
Table 1 Baseline characteristics (n = 8198) (Continued)
Singleton
(n = 8107)
Twin
(n = 91)
P-value
IMT (mm) 0.6 (0.1) 0.6 (0.1) 0.22
Distensibility (10−3/kPa) 31.3 (18.8 to 49.1) 31.9 (18.6 to 51.4) 0.37
SBP (mmHg) 114.6 (12.8) 111.2 (13.4) 0.13
DBP (mmHg) 68.6 (8.2) 67.3 (9.3) 0.40
Data are represented as n (%), mean (SD) or as the median with the 90% range. Differences in baseline characteristics were tested using Student’s t, Mann-
Whitney U and Chi-Square tests. Abbreviations: BMI Body mass index, sFLT Soluble fms-like tyrosine kinase 1, PGF Placental growth factor, SBP Systolic blood
pressure, DBP Diastolic blood pressure, IMT Intima media thickness
Table 2 Association of outcome measures in women with a previous singleton or twin pregnancy
Singleton
(n = 8107)
Twin
(n = 91)
sFLT MoM
β (95% CI)
PGF MoM
β (95% CI)
Early pregnancy Basic model Reference 0.61 (0.45 to 0.78)* 0.55 (0.35 to 0.76)*
Confounder model Reference 0.64 (0.48 to 0.79)* 0.56 (0.36 to 0.77)*
Mid-pregnancy Basic model Reference 1.06 (0.85 to 1.26)* 1.02 (0.87 to 1.17)*
Confounder model Reference 1.10 (0.90 to 1.30)* 1.05 (0.90 to 1.20)*
Singleton
(n = 5133)
Twin
(n = 61)
Six years Arteriolar retinal
calibre (SDS)
Venular retinal
calibre (SDS)
PWV
(m/s)
Basic model Reference −1.50 (−4.09 to 1.08) 1.95 (−1.51 to 5.42) −0.21 (−0.59 to 0.18)
Confounder model Reference −1.43 (−6.51 to 3.65) 1.81 (−4.94 to 8.57) −0.20 (−0.59 to 0.19)
Aortic root
diameter (mm)
Left atrial
diameter (mm)
Left ventricular
mass (g)
Fractional
Shortening
Basic model Reference −0.24 (−0.60 to 0.12) 0.26 (−0.24 to 0.75) 7.65 (−0.25 to 15.56) −0.81 (−2.05 to 0.43)
Confounder model Reference −0.39 (−1.08 to 0.31) 0.15 (−0.72 to 1.02) 5.82 (−1.49 to 13.12) −0.85 (−2.09 to 0.40)
SBP (mmHg) DBP (mmHg)
Basic model Reference −1.92 (−5.20 to 1.37) −2.20 (−4.77 to 0.37)
Confounder model Reference −1.85 (−5.04 to 1.34) −1.97 (−4.45 to 0.50)
Singleton
(n = 4655)
Twin
(n = 53)
Ten years IMT (mm) Distensibility (10−3/kPa) SBP (mmHg) DBP (mmHg)
Basic model Reference 0.00 (−0.02 to 0.02) 2.53 (−0.31 to 5.36) −4.44 (−8.87 to −0.01)* −2.50 (−5.37 to 0.37)
Confounder model Reference 0.00 (−0.02 to 0.02) 2.10 (−0.67 to 4.87) −3.38 (−7.54 to 0.78) −1.96 (−4.75 to 0.84)
Values are regression coefficients with the 95% confidence interval (CI) and are based on linear regression models. Women with the use of antihypertensive
medication were excluded for blood pressure analyses. Basic model: adjusted for maternal age at intake and interval time. Arteriolar retinal calibre is additionally
adjusted for venular calibre and vice versa. PWV is additionally adjusted for pulse at the time of PWV assessment. Confounder model: basic model additionally
adjusted for ethnicity, educational level, parity, smoking, method of conception, and BMI at intake. Abbreviations: sFLT Soluble fms-like tyrosine kinase 1, PGF
Placental growth factor, PWV Pulse wave velocity, IMT Intima media thickness, SBP Systolic blood pressure, DBP Diastolic blood pressure, BMI Body mass index. *
p-value < 0.05
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CI −8.87 to −0.01). After adjustment for confounders
this association was no longer significant. Twin pregnan-
cies were not associated with DBP 10 years after preg-
nancy (Table 2). Six years after pregnancy, no
differences were found for women with twin pregnancies
compared to women with singleton pregnancies regard-
ing microvasculature, including arteriolar and venular
retinal calibres. In addition, also no differences were
found in macrovasculature 6 years after pregnancy, in-
cluding PWV, left atrial diameter, aortic root diameter,
fractional shortening and left ventricular mass. Ten years
after pregnancy, no difference was found for IMT or dis-
tensibility as measure for elasticity in the CCA of women
with twin pregnancies compared to women with single-
ton pregnancies (Table 2). We found no difference in
SBP, DBP, retinal microvasculature, echocardiographic,
and CCA measurements 6 and 10 years after pregnancy
in women with twin pregnancies and PE compared to
women with twin pregnancies without PE (data not
shown).
Discussion
Our study shows a different maternal adaptation to
pregnancy in women with twin pregnancies compared to
women with singleton pregnancies. Women with twin
pregnancies have higher levels of sFLT-1 and PGF, a dif-
ferent DBP pattern in pregnancy and a higher risk for
PE. Years after pregnancy, there seem to be no
remaining cardiovascular differences in women with pre-
vious twin pregnancies compared to those with singleton
pregnancies.
The increased risk of PE in women with twin pregnan-
cies found in this study is in agreement with previous
studies [4–6]. It was previously suggested that this
Table 3 Association of pre-eclampsia in women with a singleton or twin pregnancy
PE
OR (95% CI)
Mediation
OR (95% CI)
Singleton Twin sFLT / PGF ratio
Basic model Reference 2.90 (2.03 to 4.16) Direct effect 2.18 (1.38 to 3.43)
Confounder model Reference 3.63 (1.76 to 7.48) Direct effect 2.63 (1.05 to 6.57)
Placenta model Reference 6.76 (2.81 to 16.24) Direct effect 4.35 (1.43 to 13.22)
Data are represented as the odds ratio (OR) with the 95% confidence interval (CI) and are based on logistic regression models. The represented direct effect is the
OR of women with twin pregnancies to develop PE if you take the mediating role of sFLT and PGF in early pregnancy into account. Basic model: adjusted for
maternal age at intake and gestational age at birth. Confounder model: basic model additionally adjusted for ethnicity, educational level, parity, smoking, method
of conception and BMI at intake. Placenta model: confounder model additionally adjusted for placental weight. Abbreviations: PE Pre-eclampsia, sFLT Soluble fms-
like tyrosine kinase 1, PGF Placental growth factor
Fig. 1 Blood pressure patterns in pregnancy stratified for women with singleton and twin pregnancies. a Change in systolic blood pressure in mmHg
in women with singleton and twin pregnancies based on repeated measurements analyses. Data represent the unadjusted blood pressure pattern.
Systolic blood pressure = β0 + β1 * pregnancy outcome + β2 * gestational age + β3 * gestational age ^ -2 + β4 * pregnancy outcome * gestational
age. Women with the use of antihypertensive medication were excluded for blood pressure analyses (n = 11). b Change in diastolic blood pressure in
mmHg in women with singleton and twin pregnancies based on repeated measurements analyses. Data represent the unadjusted blood pressure
pattern. Diastolic blood pressure = β0 + β1 * pregnancy outcome + β2 * gestational age + β3 * gestational age ^ 0.5 + β4 * pregnancy outcome *
gestational age. Women with the use of antihypertensive medication were excluded for blood pressure analyses (n = 11)
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increased risk was mediated through increased levels of
sFLT-1 as a result of higher placental mass [9]. In our
study the higher risk of PE in women with twin pregnan-
cies could not be fully explained by higher placental
mass, since women with twin pregnancies still show an
increased risk of PE, even after taking placental weight,
sFLT-1 and PGF into account. This suggests that the in-
creased risk of PE in women with twin pregnancies is
not merely the result of different placentation.
The average trajectory of blood pressure in preg-
nancy which decreases until mid-pregnancy and in-
creases in late pregnancy, has been well described in
women with singleton pregnancies [31]. For DBP, a
different pattern was found in women with twin preg-
nancies compared to women with singleton pregnan-
cies. We speculate a different physiologic basis for
this difference. The higher DBP from mid-pregnancy
onwards may be the effect of an increased intravascu-
lar volume, resulting in an increased DBP from mid-
pregnancy onwards. Previously, Gaillard et al. showed
that second to third trimester increase in BP is asso-
ciated with an increased risk of gestational hyperten-
sive disorders [32]. This is in agreement with our
findings, showing that women with twin pregnancies
have a higher increase in DBP from mid- to late
pregnancy compared to women with singleton preg-
nancies resulting in a higher risk of PE.
Inadequate adaptation to pregnancy reveals dimin-
ished maternal reserves of women’s cardiovascular
system. Therefore, pregnancy acts as a medical stress
test for women [33]. It is thought that inadequate
adaptation to pregnancy through endothelial dysfunc-
tion leads to a cascade of events that progresses to
atherosclerosis and contributes to the risk of CVD
[34]. Additionally, women at risk of CVD have risk
factors as obesity, hyperlipidaemia and hypertension,
also associated with endothelial dysfunction [35].
Since twin pregnancies demand a greater maternal
adaptation, we hypothesized that women with twin
pregnancies might have an increased risk of CVD by
the increased risk of PE associated with persistent
endothelial damage. Our study shows that women
with twin pregnancies have a different adaptation dur-
ing pregnancy compared to women with singleton
pregnancies, but years after pregnancy these differ-
ences seem to resolve, not leading to an increased
risk of CVD. Additionally we repeated the same ana-
lyses in women with twin pregnancies and PE com-
pared to women with twin pregnancies without PE.
No associations were found for women with twin
pregnancies and PE. This may be explained by the
relative small number of women with twin pregnan-
cies in our study. In previous studies performed in
women with singleton pregnancies, we did find
associations years after pregnancy in women with PE
compared to women without PE [28, 36]. However, it
might also be that PE in women with twin pregnan-
cies is potentially a different phenotype compared to
PE in women with singleton pregnancies, independ-
ently from cardiovascular predisposition of mothers.
Therefore we assume that PE and the link with CVD
in women with singleton pregnancies can not be
compared to PE in women with twin pregnancies. We
hypothesize that the differences in adaptation during
pregnancy in women with twin pregnancies are the
result of the higher demand of both foetuses rather
than failing pregnancy as cardiovascular stress test
resulting in a higher risk of cardiovascular disease
later in life.
Strengths and limitations
A limitation is that the number of women with twin
pregnancies in this study is rather low compared to
the number of women with singleton pregnancies,
therefore we performed the same analyses in a
smaller number of selected women with singleton
pregnancies (n = 199) matched on maternal age, ethni-
city and level of education. Since this resulted in the
same conclusions, we assume that the difference in
group size did not influence our results. Due to in-
complete information on chorionicity, no multivariate
analysis was performed. Another limitation is that
since this is a cohort study, measurements were re-
stricted to standardized moments as part of the study
design. We did not obtain outcomes of all women
years after pregnancy. Six and ten years after preg-
nancy we obtained data from 63% at most. Nonre-
sponse analyses showed that women with no
attendance 10 years after pregnancy tended to be
younger at intake, to be of non-Western descent, to
have a lower level of education, to be more often nul-
liparous, to have a higher BMI and to smoke more
often during pregnancy. They were also more likely
to have an earlier gestational age at birth, more often
delivered prematurely and their children had a lower
birth weight (Table 4). If the selection mechanisms
have been related to both determinant and outcome,
this may have led to biased effect estimates. However,
given the prospective nature of the study, this seems
unlikely. It is impossible though, to exclude that this
may influence our results. Another limitation is that
we were restricted to pre-specified visiting moments.
Therefore, 6 and 10 years after pregnancy may not be
the best moments to measure cardiovascular adapta-
tion. However, previous studies in women with single-
ton pregnancies did find differences for women with
PE within this time period [28, 36].
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Conclusions
This study demonstrates that in pregnancy, differences
in adaptation are present in women with a twin preg-
nancies compared to women with singleton pregnancies.
These differences seem to resolve years after pregnancy.
Therefore, women with twin pregnancies show no direct
association with CVD later in life compared to women
with singleton pregnancies.
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Table 4 Maternal characteristics stratified for response ten years after pregnancy (n = 8198)
Visit ten years after pregnancy
(n = 4708)
No visit ten years after pregnancy
(n = 3490)
P-value
Maternal characteristics
Age at intake (years) 30.6 (4.9) 28.0 (5.4) < 0.001
Non-Western ethnicity (%) 1734 (36.8) 1953 (56.0) < 0.001
Lower education (%) 2483 (52.7) 2541 (72.8) < 0.001
Nulliparous (%) 2900 (61.6) 1905 (54.6) < 0.001
Assisted conception (%) 280 (5.9) 274 (7.9) 0.01
BMI at intake (kg/m2) 24.0 (19.6 to 33.2) 24.4 (19.3 to 35.0) 0.002
Smoking during pregnancy (%) 1198 (25.4) 1212 (34.7) < 0.001
Birth
Gestational age at birth (weeks) 40.1 (36.9 to 42.1) 40.0 (36.3 to 42.1) < 0.001
Premature birth < 37 weeks (%) 241 (5.1) 246 (7.1) < 0.001
Premature birth < 34 weeks (%) 58 (1.2) 68 (1.9) 0.01
Birth weight (g) 3411.0 (559.3) 3336.7 (601.0) < 0.001
Weight placenta (g) 640.0 (153.7) 644.2 (168.4) 0.79
Data are represented as n (%), mean (SD) or as the median with the 90% range. Differences in baseline characteristics were tested using Student’s t, Mann-
Whitney U and Chi-Square tests. Abbreviations: BMI Body mass index
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